PRA Health Sciences, Inc. provided earnings guidance for the year 2019. The company is updating its 2019 revenue guidance to between $3.02 billion and $3.10 billion, representing as reported growth of 5% to 8% and constant currency growth of 6% to 8%, GAAP net income per diluted share to between $3.60 and $3.70.